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Abstract To date, the effectiveness of psychotherapy for
the treatment of most mental disorders is empirically well
documented. From an ‘‘evidence-based medicine’’ view-
point, psychotherapy, as compared to other treatments in
medicine, can be regarded as one of the most effective
therapeutic approaches. The superiority of psychotherapy
over pharmacotherapy is particularly pronounced in long-
term treatment outcome studies. It is especially cognitive
behavioral approaches, such as exposure response man-
agement and cognitive restructuring that have shown
strong evidence of their efficacy and effectiveness in var-
ious populations and settings. However, evidence-based
medicine is by definition oriented toward the past, as it
only informs us about the well-established, empirically
supported treatments. If we rely only on the currently
available scientific evidence, new developments will be
blocked. Since, for instance, many patients decline treat-
ment, or do not seek professional help at all, there is a need
for improvements regarding acceptance of established
therapies. In addition, there ought to be scope for new,
creative approaches, for which scientific evidence is not yet
available. Promising developments include the mindful-
ness-based therapies, well-being therapy, the use of cog-
nitive enhancers such as D-cycloserine, and Web-based
therapies. There is also a trend in psychotherapy training
toward teaching specific, disorder-oriented protocols or
modules rather than universally applicable therapies.
Finally, given the globalization of our societies, culture-
sensitive psychotherapists should try to understand the
cultural components of a patient’s illness and help-seeking
behaviors, as well as their expectations with regard to
treatment.
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Psychotherapy: status quo
What is psychotherapy?
According to Senf and Broda’s textbook [30], psychother-
apy is a scientifically based form of professional action
within the framework of the public health-care system and
in accordance with its rules. Psychotherapy positioned in
this way is based on scientifically comprehensible and
empirically supported theories of illness, healing and treat-
ment. Moreover, psychotherapy uses theoretically derived
and empirically supported procedures, methods and settings
to bring about a targeted change in experience and behavior
to treat or prevent illnesses, disorders or complaints, whose
causes are wholly or partly psychological. Such a procedure
presupposes a thorough diagnosis and a differential diag-
nosis as well as a qualified differential indication. Moreover,
psychotherapy is practised with treatment targets formu-
lated beforehand and evaluated afterwards. At the end of
their definition, Senf and Broda stress that psychotherapy is
conducted by professional psychotherapists, whose profes-
sional qualification has been demonstrated through exami-
nation, maintains ethical principles and standards and,
finally, satisfies measures of quality assurance and adheres
to the economic imperative [30].
In short, a scientifically based psychotherapy is rooted in
empirically supported theories of illness, healing and
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treatment. It applies theoretically derived and evidence-
based procedures to try and bring about a deliberate change
in the experience and behavior of patients and, in so doing,
treats or prevents mental illnesses.
Does it work?
Psychotherapy can be considered as one of medicine’s
most effective therapeutic approaches. By no means does
psychotherapy need to hide away, for instance, from the
comparison with drug treatment or surgery. Take, for
example, the prescribing of acetylsalicylic acid to prevent
myocardial infarction, which has an effect size (treated
versus untreated) of 0.07. Medication for rheumatoid
arthritis scores 0.61, which is already in the mid-range of
effect sizes, whereas aorto-coronary bypass surgery has a
comparatively high effect size of 0.80. The effect size of
psychotherapy is 0.88, which is within the same order of
magnitude, and that is taking all psychotherapeutic
approaches together. If the cognitive behavioral therapies
are considered separately, their effect size is as high as 1.21
[8, 10, 16, 17].
Across the majority of mental disorders, most of the
therapeutic effect of psychotherapy is achieved within the
first 10–20 sessions. This concerns not only the reduction
in symptoms, but also the improvement in the patients’
subjective feeling of wellbeing and their psycho-social
functional level [16, 18]. On the other hand, there are of
course patients with chronic mental disorders, such as
severe personality disorders, who do need long-term psy-
chotherapy, sometimes over many years [15]. There is also
good evidence for the long-term stability of the results once
the psychotherapy has been completed. However, this
applies, in particular, for cognitive behavioral therapy, but
much less so for psychodynamic treatments and relaxation
techniques [20].
Use of effective treatments in clinical practice
Despite all these positive reports on the effectiveness of
psychotherapy, one big problem still persists: those thera-
peutic approaches whose effectiveness has been scientifi-
cally proven are still used much too little in everyday
clinical psychotherapeutic practice. This was demon-
strated, for example, in a large representative study carried
out in Switzerland into the treatment of anxiety and
depression to establish which therapeutic approaches were
actually used in real routine practice. Patients with anxiety
and depressive disorders were only relatively rarely given
treatments whose efficacy was well documented (cognitive
therapy and behavioral therapy: 12%, hypnosis and relax-
ation techniques: 39% of all cases), whereas supportive
counseling and pharmacotherapy, which have been
demonstrated to promise less lasting success, were used in
70-90% of cases (Margraf, in preparation). It has been
known for a long time that only a small percentage of
patients suffering from anxiety or depressive disorders are
treated by adequately trained specialists. The study just
mentioned shows, moreover, that, of these few patients
who have access to professional treatment, only a small
proportion, in turn, benefit from evidence-based therapies.
Thus, in Europe, we find ourselves faced with a some-
what strange situation. There are many good, fully trained
and clinically experienced psychotherapists working in
specialized institutions or in private practice. Today, very
effective treatment options are available for the most fre-
quently occurring mental disorders, and most people have a
health insurance which would cover a large part of the
treatment costs. Yet most sufferers of mental disorders are
either not receiving any professional treatment at all, or the
effectiveness of one they are receiving is not scientifically
proven.
Evidence-based psychotherapy
Chambless and Hollon [2] postulate that the following
criteria would have to be met for a therapeutic approach to
be ‘‘evidence-based’’ and/or ‘‘empirically supported’’: the
efficacy of the approach must have been demonstrated by a
series of randomized controlled trials (RCTs), using
appropriate samples and control groups; the samples must
have been adequately described; valid and reliable outcome
assessments must have been used; and, finally, the results
must have been replicated by at least one independent
group of researchers. Foa and colleagues make the point
that the use of more rigorous scientifc methods in psy-
chotherapy outcome research has increased dramatically in
the course of the past 25 years. As a representative
example, they describe for the field of traumatic stress
research the following features which a well-controlled
trial should have [6]:
• Clearly defined target symptoms.
• Reliable and valid measures that allow to establish
reliably both symptom severity as well as diagnostic
status.
• Use of blinded evaluators.
• Assessor training to ensure inter-rater reliability and to
prevent evaluator drift.
• Manualized, replicable, specific treatment protocols.
• Equipoise with regard to treatment conditions.
• Unbiased assignment to treatment.
• Treatment adherence ratings.
• Data analysis conducted according to accepted
procedures.
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Efficacy versus effectiveness
The purpose of efficacy studies is to examine whether or not an
intervention has an effect in ideal conditions in which all the
influences can be measured and monitored with precision. It
may happen in such trials that the patients are not represen-
tative of the everyday clinical situation or only partially so.
The research design for efficacy studies stresses internal
validity, and for this purpose it is common to perform
completers analyses. If such a trial is carried out in properly
controlled conditions it may, however, supply valuable
information as regards the specificity of the intervention.
Effectiveness studies are different in that they ask the
question as to whether or not a particular intervention
produces an effect in real clinical conditions. It thus fol-
lows that the patients selected for the trial should be more
representative of the everyday clinical population. This sort
of study design stresses external validity. It is typical for
effectiveness studies to perform intent-to-treat analyses.
Such trials, however, provide only limited information on
the specificity of an intervention.
Thus both efficacy and effectiveness studies have their
specific advantages and disadvantages. It would therefore
be wrong to want to play them off against one another. On
the contrary, it is possible for them to complement one
another in a meaningful way, quite apart from the fact that
case studies, naturalistic studies, process research and other
approaches can provide important additional information to
the overall judgment of a therapeutic approach. In sub-
sequent stages of research, attempts are made to understand
the mechanism of action more precisely by performing
dismantling or component control studies.
Dissemination of evidence-based therapies
Why is it that, although effective psychotherapeutic inter-
ventions are available today for the commonest mental
disorders, the majority of patients either receive no pro-
fessional treatment at all or, if they do make their way into
professional hands, the therapy that is provided will often
not be one for which there is sufficient empirical support?
One reason is that today most psychotherapists are still
not adequately trained in empirically supported treatments.
Secondly, many psychotherapists do not like working with
treatment manuals; in most cases, they have had no expe-
rience with using treatment manuals and are afraid that
following treatment steps laid down in a manual will
constrain them from giving free reign to their creativity.
The other side to this is that both patients and health
insurance companies are increasingly demanding the use of
evidence-based procedures. Therefore, evidence-based
medicine is going to shape our everyday lives as therapists.
However, having said that, it should also be kept in mind
that evidence-based medicine is, by its very definition,
based on, and oriented toward, the past; it informs us of the
results that have been produced by research up until the
present day. If a new intervention has not been empirically
studied, it does not mean that it is not effective—it merely
indicates that, for the time being, there is still no scientific
evidence of its effectiveness.
A greater dissemination of evidence-based therapies in
clinical practice is absolutely indispensable. However, if we
simply rely on the principles of evidence-based medicine
and leave it at that, things will come to a standstill and
creative further developments and new developments will
be rendered impossible. Genuine scientific progress is only
possible if there are creative therapists and researchers who
are repeatedly willing to risk trying out new ideas. How-
ever, these innovations must, in their turn, face up to critical
scientific scrutiny. If sober examination proves that they are
ineffective, we must abandon them again, no matter how
attractive and promising they might appear to be. If they are
effective, these new developments will sooner or later make
their way onto the palette of treatments from which the
therapist can choose – perhaps as a totally new approach in
their own right, perhaps as a new technique, or perhaps as a
complement to existing interventions.
Roth and Fonagy, too, place innovative practice at the
beginning of a feedback loop—actually one with several
sub-loops, within which the field of psychotherapy devel-
ops further, finally resulting in improved psycho-social
care [25]. They see innovative practice as stimulating the
evaluation of case series. New concepts emerging from this
are taken up by psychotherapy research and are investi-
gated in randomized controlled trials. The results of this
research are fed into professional consensus conferences
and have their impact on the development of guidelines.
When the latter are, in turn, put into effect, they change
clinical practice and lead to an improvement in clinical
care through quality-control measures. In addition to this,
they also bring about adaptations in training at all levels
(initial, advanced and continuous). The experience from
clinical practice combined with data from quality man-
agement might then provide the occasion for a new round
of innovative adaptations in the way patients are dealt with
clinically, and, in that way, the creative circle will have
completed its 360 turn. Additionally, the process is also
sustained and driven forward by external stimuli and
inputs, originating, for instance, in basic neurobiological
research or innovations in psychopathology.
Promising developments in psychotherapy
If existing psychotherapies are as effective and successful
as stated above, why should there be any need at all for
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further progress? Is it not possible to consider psycho-
therapy as a form of treatment that has reached maturity?
Would it thus not be our priority to make sure that the
effective interventions were disseminated as widely as
feasible, so that as many patients as possible would be able
to benefit from them? Yes, but there are still several good
reasons [28] militating in favor of further enhancements in
the spectrum of psychotherapeutic interventions as well as
advancing the further continuation of developments, addi-
tions and extensions to this spectrum. Here are some of
those reasons:
• Not all patients are willing to subject themselves to an
empirically supported therapy. Exposure, for example,
is considered today to be the treatment of choice
for most anxiety disorders, including obsessive com-
pulsive disorders. There are, however, patients who, for
comprehensible reasons, cannot agree, at least at a
given point in time, to undergo confrontation therapy of
this nature.
• The overall dropout rates for empirically supported
therapies are approximately 20% [1].
• Around 50% of the patients who complete an evidence-
based treatment schedule with success and with a
clinically relevant symptom reduction, will still satisfy
the diagnostic criteria for the disorder that took them
into the treatment to begin with [23, 31].
• Around 50% of patients do not attain a satisfactory
psycho-social functional level, even if their symptoms
have decreased significantly [21, 23]. At the end of
treatment, many patients are still impaired as regards
their ability to perform employed work, the quality of
their relationships, and their general satisfaction with
life.
• One final point is that there is still too little on offer
today for patients who do not find their way into
psychotherapy, for reasons such as not finding a
therapist speaking their language, not being able to
attend a psychotherapeutic practice on account of a
physical disability, or fearing stigmatization on account
of their exposed position within society.
Against the background of all the reasons just outlined,
the following sections go on to present a number of
examples of creative further developments or new devel-
opments. These are worthy of discussion, since they have
the potential of contributing to more finely tuned differ-
entiation amongst the possible psychotherapeutic inter-
ventions currently available.
Mindfulness and acceptance
The ‘‘mindfulness-based therapies’’ are certainly to be
counted amongst the most important further developments
and additions to cognitive behavioral therapies in recent
years [9]. Kabat-Zinn [11] detached mindfulness from its
original Buddhist context and developed a form of training
in mindfulness meditation as a complement for treatment
of chronic pain, known as ‘‘mindfulness-based stress
reduction’’. It was about 10 years ago that cognitive-
behavioral therapy took up the notion of mindfulness and
integrated it as an addition in its therapeutic concepts,
which up until then had been comprised almost exclusively
of strategies focused on bringing about changes. After the
‘‘cognitive shift’’ of the 1980s and the ‘‘emotional shift’’ of
the 1990s, the integration of elements based on mindful-
ness in the first decade of the 21st century is referred to
as the ‘‘third wave’’ (or ‘‘shift’’) in cognitive-behavioral
therapy. In the meantime, mindfulness-based cognitive
therapy (MBCT) has yielded good evidence of its effec-
tiveness for major depression, treatment-resistant depres-
sion and residual depressive symptoms [19, 32]. Other
mental disorders are currently undergoing evaluation.
Well-being therapy
On the basis of Ryff’s multidimensional cognitive model of
psychological wellbeing [26, 27], Fava developed a short,
manual-based psychotherapy. Conceptually, this differs
enormously from traditional psychotherapeutic approaches.
In a course of eight clearly structured psycho-educative,
directive therapy sessions focused on solutions, the thera-
pist does not talk to the patient about problems or symp-
toms. On the contrary, the focus is solely on enhancing the
patient’s sense of wellbeing [3]. The aim of the treatment is
to achieve an improvement in the following six dimen-
sions: environmental mastery, personal growth, purpose in
life, autonomy, self-acceptance, and positive relations with
others. The techniques used are self-observation, keeping a
structured diary, cognitive restructuring, problem-solving
strategies, self-assertiveness training, planned activities for
mastering daily life, leisure and homework. Well-being
therapy has been used successfully for preventing relapse
in recurrent depression [4, 5]. However, it also appears to
perform well for treatment-resistant depressions and anxi-
ety disorders as well as for psycho-somatic disorders and
post-traumatic stress disorders.
Cognitive enhancers
D-cycloserine was developed in the 1950s for the treat-
ment of tuberculosis. It was only recently discovered
that the compound can also influence learning behavior.
It was demonstrated that the administration of 50 mg of
D-cycloserine immediately prior to each session improved
the effect of exposure therapy for fear of heights [24]. This
effect appears to be related to the substance properties as a
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partial glutamate receptor agonist. It has also been
administered successfully to augment CBT interventions
for other anxiety disorders and a series of other mental
disorders, including depression, eating disorders, substance
dependence, and schizophrenia [22].
The experience with D-cycloserine shows that there are
no longer any valid grounds for maintaining the earlier
distinction and clear demarcation between ‘‘psychological’’
and ‘‘pharmacological’’ approaches to therapy. These two
principles of action have now been thoroughly intermixed
and act as valuable complements for one another. There
can be no doubt that this development is going to go fur-
ther. There are, for instance, already examples of hor-
mones, such as cortisol or oxytocin, being used in
combination with psychotherapy.
Web-based therapies
Starting around the mid 1990s, internet-based treatment
protocols have been developed in which patients and
therapists never come face-to-face. Many internet-based
self-help offers are available today, and there are also
psychotherapies in the strict sense of the term. They seem
to function well for various types of mental disorders, and
are intensively used, although it appears that, for the time
being, their users are primarily younger patients. As an
example, ‘‘Interapy’’ is a fully web-based writing therapy
for post-traumatic stress disorder [14]. The treatment is
comprised of ten writing sessions, divided into three pha-
ses: self-confrontation, cognitive restructuring and social
sharing. Initial investigations into Interapy show sub-
stantial and sustained symptom reduction over a follow-up
period of 18 months. The vast majority of the patients
treated indicated that they had experienced the internet
contact with their therapists as ‘‘personal’’, that they had
found the internet to be an agreeable medium of commu-
nication and, interestingly, that it had not been a problem
for them never to have come face-to-face with their ther-
apists [13, 34].
Integrated training in evidence-based, disorder-specific
therapies
There has been a recent trend to move more and more away
from universally applicable therapies toward the develop-
ment of disorder-specific protocols or therapeutic modules
for specific problems such as emotion regulation, which
can occur in conjunction with a whole range of disorders.
Accordingly, in the field of advanced and continuous
training, there is an ever-increasing number of programs on
offer aiming to impart therapeutic knowledge and skills
concerning empirically supported therapeutic approaches
within a defined diagnostic spectrum. For instance,
psychotherapists with clinical experience, who would like
to intensify their knowledge and skills in the area of psy-
chotraumatology, can now enroll in a master’s course in
psychotraumatology at Zurich University (http://www.mas-
psychotraumatology.uzh.ch). Its main emphasis is on
mediating evidence-based treatments for post-traumatic
stress disorder. The course is built on ‘‘blended learning’’,
which means that traditional learning methods (lectures,
problem-oriented learning in small groups and group
supervision) are combined with e-learning (online learning
resources, web forum, podcasts and so on). This is a setup
that facilitates asynchronous learning, so that it is possible
for students from the whole German-speaking world to
enroll [29].
Culture-sensitive psychotherapy
Tseng defines culture as a dynamic concept referring to a
set of beliefs, attitudes, and value systems that derive from
early stages of life through enculturation, and become an
internal mode of regulating behavior, action, and emotion
[33]. Thus, culture is not static, but changing continuously
across generations, responding to ever-changing environ-
mental demands. Furthermore, culture in this sense is
specific for each individual and therefore much more
important than ethnicity or race. Experienced therapists
usually tailor psychotherapy to each patient’s particular
situation, to the nature of psychopathology, to the stage of
therapy, and so on. Treatment could be a lot more effective,
however, when the cultural dimension is factored in. The
resulting culturally relevant, culture-sensitive, or culture-
competent psychotherapy involves trying to understand
how culture enhances the meaning of the patient’s life
history, the cultural components of a patient’s illness and
help-seeking behaviors, as well as the patient’s expecta-
tions with regard to treatment.
The profile of future psychotherapists
More than a decade ago, Nobel prize winner Eric Kandel
wrote that ‘‘Insofar as psychotherapy or counseling is
effective and produces long-term changes in behavior, it
presumably does so through learning, by producing chan-
ges in gene expression that alter the strength of synaptic
connections and structural changes that alter the anatomical
pattern of interconnections between nerve cells of the
brain. As the resolution of brain imaging increases, it
should eventually permit quantitative evaluation of the
outcome of psychotherapy [12]. Today, ‘‘neuropsycho-
therapy’’ [cf. Ref. [7] and the contribution by Walter and
Berger in this issue] has become a reality. Therefore,
modern psychotherapists are required to integrate profound
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knowledge and advanced skills not only in developmental
psychology, psychological theories, psychopathology, and
intervention techniques, but in neurosciences and anthro-
pology as well. We need to encourage translational
research that transfers advances in basic science to clinical
applications, foster the clinician-researcher dialogue, and
promote more interdisciplinary collaborative learning.
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